KRAS and neoplasm: An OR calculation allowed for the identification of KRAS mutation association with specific clinicopathological features, as follows: histological cribriform pattern [p = 0.018; OR: 3.127 (1.333 ÷ 7.335)], N2 lymph node involvement [p < 0.001; OR: 2.969 (1.343 ÷ 6.563)], venous vascular invasion [p = 0.048; OR: 2.205 (1.000 ÷ 4.866)], and 7–12 tumour buds [p = 0.007; OR: 2.